Spots Global Cancer Trial Database for renal insufficiency, chronic
Every month we try and update this database with for renal insufficiency, chronic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients | NCT01817699 | Kidney Transpla... Anemia Vitamin D Defic... Renal Insuffici... | High Hb target cholecalciferol | 20 Years - 79 Years | CANDLE-KIT Trial Study Group | |
| Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 | NCT02282813 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 Capsule... Calcitriol Doxercalciferol Paricalcitol | 18 Years - | OPKO Health, Inc. | |
| Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT) | NCT01219855 | Chronic Kidney ... Secondary Hyper... Vitamin D Insuf... | Cohort 1 CTAP10... Cohort 1 CTAP10... Cohort 1 Matchi... Cohort 2 CTAP10... Cohort 2 Matchi... | 18 Years - 85 Years | OPKO Health, Inc. | |
| Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency | NCT01704079 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 30 μg c... Sugar pill to C... | 18 Years - | OPKO Health, Inc. | |
| Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 | NCT02282813 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 Capsule... Calcitriol Doxercalciferol Paricalcitol | 18 Years - | OPKO Health, Inc. | |
| Treatment of Secondary Hyperparathyroidism in the Uremic Patient | NCT00469599 | Secondary Hyper... Chronic Kidney ... Vitamin D Defic... | paricalcitol alfacalcidol | 18 Years - | Zealand University Hospital | |
| Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency | NCT01651000 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 30 μg c... Sugar pill to C... | 18 Years - | OPKO Health, Inc. | |
| Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients | NCT01817699 | Kidney Transpla... Anemia Vitamin D Defic... Renal Insuffici... | High Hb target cholecalciferol | 20 Years - 79 Years | CANDLE-KIT Trial Study Group | |
| Project to Improve Communication About Serious Illness - Pilot Study | NCT03746392 | Malignant Neopl... Leukemia, Lymph... Lung Disease Ch... Congestive Hear... Liver Failures,... Renal Insuffici... Dementia Diabetes Compli... Peripheral Vasc... Frail Elderly | Jumpstart Inter... | 18 Years - | University of Washington | |
| Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose | NCT00891813 | Secondary Hyper... Renal Insuffici... Parathyroid Hor... Hemodialysis Hypercalcemia | Zemplar (parica... | 18 Years - | Abbott | |
| Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose | NCT00891813 | Secondary Hyper... Renal Insuffici... Parathyroid Hor... Hemodialysis Hypercalcemia | Zemplar (parica... | 18 Years - | Abbott | |
| Treatment of Secondary Hyperparathyroidism in the Uremic Patient | NCT00469599 | Secondary Hyper... Chronic Kidney ... Vitamin D Defic... | paricalcitol alfacalcidol | 18 Years - | Zealand University Hospital | |
| Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT) | NCT01219855 | Chronic Kidney ... Secondary Hyper... Vitamin D Insuf... | Cohort 1 CTAP10... Cohort 1 CTAP10... Cohort 1 Matchi... Cohort 2 CTAP10... Cohort 2 Matchi... | 18 Years - 85 Years | OPKO Health, Inc. | |
| Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT) | NCT00792857 | Chronic Kidney ... Secondary Hyper... Chronic Renal I... Chronic Renal F... | CTAP201 Injecti... Doxercalciferol | 18 Years - 80 Years | OPKO Health, Inc. | |
| Project to Improve Communication About Serious Illness - Pilot Study | NCT03746392 | Malignant Neopl... Leukemia, Lymph... Lung Disease Ch... Congestive Hear... Liver Failures,... Renal Insuffici... Dementia Diabetes Compli... Peripheral Vasc... Frail Elderly | Jumpstart Inter... | 18 Years - | University of Washington |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
